key: cord-0748617-br4ssimq
authors: Aslan, Nagehan; Yildizdas, Dincer; Sinanoglu, Muhammed Selcuk
title: A Pediatric COVID19 Case with Suspected Acute Abdomen, Hyperferritinemic Sepsis and Developing MIS-C and Pancreatitis
date: 2020-10-22
journal: Indian J Pediatr
DOI: 10.1007/s12098-020-03544-0
sha: 1c10da01d4bc330ff81ab0f9a3d1fe2f3266fee2
doc_id: 748617
cord_uid: br4ssimq

nan

To the Editor: Multisystem inflammatory syndrome in children (MIS-C), that develops in children due to COVID-19 is a rare but serious condition associated with COVID-19 reported in children [1] .

A healthy 12-y-old female patient had been admitted with abdominal pain, vomiting and fever and hospitalized with a prediagnosis of acute appendicitis. Surgical intervention decision was abandoned in the patient whose diarrhea started. SARS CoV2 RT-PCR test was positive. Abdominal CT revealed multiple lymphadenopathies with an edematous appearance compatible with typhlitis in terminal ileum. Broad-spectrum antibiotics and antiviral therapies were administered. COVID-19associated MIS-C was considered in the patient. Because the patient's fever was above 38°C and was resistant to antipyretics, there was no decrease in infectious parameters, his lymphopenia did not improve; albumin level did not increase despite albumin replacement, and respiratory and gastrointestinal symptoms continued. IVIG 2 g/kg was administered as a 12-h infusion. The patient's fever decreased dramatically after IVIG infectious parameters regressed. Pancreatitis developed on the 4th day. The patient was discharged on the 13th day.

In a pediatric series, all 8 cases presented with atypical appendicitis [2] . Radiological imaging revealed lymphadenopathy in the abdomen and terminal ileitis in all children. Three of them required inotropic support in PICU. Four patients suspected of MIS-C were given IVIG. In India, an 11-y-old patient presented with fever, abdominal pain and skin rash [3] . Radiological imaging revealed inflammation in the terminal ileum and cecum. SARS CoV2 RT-PCR test was positive, and clinical improvement was observed with IVIG treatment.

Elevated ferritin levels were associated with increased mortality in COVID-19 patients [4] . Management of hyperferritinemic sepsis can differ from sepsis without hyperferritinemia. In addition to the usual antimicrobial approach, one should consider administration of specific antivirals, antiparasitics, antibacterials, and antifungals; as well as non-specific neutralization with IVIG for infections without specific therapies in the hyperferritinemic patient [5] .

Although it is not clear whether pancreatitis in our case was related to drugs or developed as a part of the gastrointestinal presentation of COVID-19. Our case is important in terms of drawing attention that COVID-19 may present with a picture that mimics acute appendicitis in children.

Conflict of Interest None.

Hyperinflammatory shock in children during COVID-19 pandemic

Gastrointestinal features in children with COVID-19: an observation of varied presentation in eight children

COVID abdomen: SARS-CoV-2 infection presenting as 'acute abdomen' in a child

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Why and how ıs hyperferritinemic sepsis different from sepsis without hyperferritinemia?

Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations